Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-08

FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (West-Ward Pharmaceuticals Corp)

View source ↗

Summary

FDA approved a supplemental application for fosphenytoin sodium submitted by West-Ward Pharmaceuticals Corp. The action updates labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosphenytoin Sodium (fosphenytoin sodium)

Snippet

SUPPL AP for FOSPHENYTOIN SODIUM (FOSPHENYTOIN SODIUM)